Google News – Clinical Trials External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
Did NMPA’s Acceptance of HS-20093 Just Shift Hansoh Pharmaceutical Group's (SEHK:3692) Oncology Narrative? - simplywall.st
Google News – Pharmaceuticals External News
Arrowhead Pharmaceuticals (ARWR) Stock Looks Cheap On Cash Flow Yet Fair On Sales - simplywall.st
Google News – Clinical Trials External News
Novartis, Ionis drug failure spurs questions about an emerging class of heart medicines - BioPharma Dive
Google News – Pharmaceuticals External News
Why Ultragenyx Pharmaceutical (RARE) Is Down 40.3% After Aspire Trial Failure And Expense Cut Plans - simplywall.st
Google News – Clinical Trials External News
Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem. - Pharmafile
Google News – Pharmaceuticals External News
Rubber Gaskets Pharmaceutical Containers Market Outlook to 2035 - IndexBox
Google News – Pharmaceuticals External News
Hikma Pharmaceuticals (LSE:HIK) Stock Fair Value Edges Higher After Bullish Analyst Targets - Yahoo Finance
Industry News External News
Fosun Pharma sells 4.55% stake in Gland Pharma for Rs 2,121 crore - BusinessLine
Google News – FDA (biotech/pharma) External News
AstraZeneca’s Etcamah combo approved by FDA - The Pharma Letter
Google News – Pharmaceuticals External News
China Resources Pharmaceutical Group (SEHK:3320), Why Is It Getting Fresh Attention Today? - simplywall.st
Google News – Oncology External News
Sudarshan Pharma to buy 9.5% of US cancer-therapy firm MedTherapy - Dealroom
Google News – Pharmaceuticals External News
Does Pelacarsen’s Phase 3 Miss And ZANVASTRO’s FDA Win Change The Bull Case For Ionis (IONS)? - simplywall.st
Google News – Pharmaceuticals External News
European healthcare professionals view greener pharmaceutical manufacturing favorably - Bioengineer.org
Google News – Pharmaceuticals External News